Saturday 17 October 2026
Export LNSR’s income statement to Excel — free account
LENSAR, Inc.
LNSR Healthcare Medical Devices
LENSAR, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $58.4 million, up 9.24% from fiscal 2024. In the quarter to June 2026, revenue grew 18.4%, EPS grew 291.7% and free cash flow grew 96.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
5.80
0.23
−3.81%
Follow LNSR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 3 | 3 |
+8 more TTM periods Free account |
| (851.75%) | (517.96%) | 324.05% | 3,251.75% | ||
| 49.58% | 42.24% | (49.78%) | (77.94%) | ||
ROIC |
(379.01%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
124.67% | 117.31% | (511.49%) | (556.47%) | |
Average Days of Receivables |
37.37 | 30.97 | 39.83 | 36.42 | |
Free Cash Flow per Share |
(0.60) | (1.00) | (1.25) | (0.99) | |
Free Cash Flow |
(7.40) | (12.16) | (14.91) | (11.88) | |
Capital Expenditures |
(0.11) | — | (0.08) | (0.09) | |
| Other line items | |||||
Cash ROIC |
(26.01%) | (50.09%) | 185.47% | 131.42% | |
Accounts Receivable Turnover |
10.80 | 9.80 | 9.38 | 11.51 | |
Accounts Payable Turnover |
2.77 | 3.51 | 2.51 | 3.41 | |
Inventory Turnover |
1.41 | 1.63 | 1.90 | 1.79 | |
Average Days of Payables |
131.23 | 117.65 | 221.26 | 169.55 | |
Days of Inventory on Hand |
291.59 | 269.15 | 250.85 | 236.04 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
8.83% | 9.48% | 9.62% | 9.57% | |
Selling, General and Administrative Expense of Revenue |
51.47% | 63.32% | 77.28% | 70.44% | |
Share Based Compensation of Revenue |
4.58% | 5.51% | 5.38% | 4.96% | |
Operating CF/Net income |
(0.21) | (0.41) | 0.43 | 0.23 | |
Depreciation/Fixed assets |
10.09 | 9.68 | 8.56 | 7.58 | |
Capex/Depreciation |
(0.02) | 0.00 | (0.02) | (0.02) | |
Revenue per Share |
4.90 | 4.75 | 4.89 | 4.91 | |
Operating CF per Share |
(0.59) | (1.00) | (1.24) | (0.98) | |
Capex per Share |
(0.01) | 0.00 | (0.01) | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates